I

Immunome
D

IMNM

9.52000
USD
-0.60
(-5.93%)
مغلق
حجم التداول
10,702
الربح لكل سهم
0
العائد الربحي
-
P/E
-1
حجم السوق
806,105,134
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Immunome

القطاع: Healthcare
الصناعة: Biotechnology
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.